Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Liraglutide and Renal Outcomes in Type 2 Diabetes.

Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.

N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.

PMID:
28854085
2.

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators.

N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27.

PMID:
28844192
3.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators.

N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.

4.

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke.

Au JL, Weishaupt N, Nell HJ, Whitehead SN, Cechetto DF.

J Vis Exp. 2016 Mar 22;(109). doi: 10.3791/53089.

PMID:
27022854
5.

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.

Stempel DA, Raphiou IH, Kral KM, Yeakey AM, Emmett AH, Prazma CM, Buaron KS, Pascoe SJ; AUSTRI Investigators.

N Engl J Med. 2016 May 12;374(19):1822-30. doi: 10.1056/NEJMoa1511049. Epub 2016 Mar 6.

6.

Targeted Antioxidant, Catalase-SKL, Reduces Beta-Amyloid Toxicity in the Rat Brain.

Nell HJ, Au JL, Giordano CR, Terlecky SR, Walton PA, Whitehead SN, Cechetto DF.

Brain Pathol. 2017 Jan;27(1):86-94. doi: 10.1111/bpa.12368. Epub 2016 Jun 13.

PMID:
26919450
7.

Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination.

Tefit JN, Crabé S, Orlandini B, Nell H, Bendelac A, Deng S, Savage PB, Teyton L, Serra V.

Vaccine. 2014 Oct 21;32(46):6138-45. doi: 10.1016/j.vaccine.2014.08.070. Epub 2014 Sep 13.

8.

Age-Dependent Effect of β-Amyloid Toxicity on Basal Forebrain Cholinergic Neurons and Inflammation in the Rat Brain.

Nell HJ, Whitehead SN, Cechetto DF.

Brain Pathol. 2015 Sep;25(5):531-42. doi: 10.1111/bpa.12199. Epub 2014 Oct 29.

PMID:
25187042
9.

A randomized, double-blind, parallel-group, placebo-controlled trial of Extract Sceletium tortuosum (Zembrin) in healthy adults.

Nell H, Siebert M, Chellan P, Gericke N.

J Altern Complement Med. 2013 Nov;19(11):898-904. doi: 10.1089/acm.2012.0185. Epub 2013 Feb 26.

PMID:
23441963
10.

Basal insulin and cardiovascular and other outcomes in dysglycemia.

ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11.

11.

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):309-18. doi: 10.1056/NEJMoa1203859. Epub 2012 Jun 11.

12.

Strength training increases maximum working capacity in patients with COPD--randomized clinical trial comparing three training modalities.

Vonbank K, Strasser B, Mondrzyk J, Marzluf BA, Richter B, Losch S, Nell H, Petkov V, Haber P.

Respir Med. 2012 Apr;106(4):557-63. doi: 10.1016/j.rmed.2011.11.005. Epub 2011 Nov 26.

13.

Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer.

Clearie KL, Williamson PA, Vaidyanathan S, Du Bois J, Nell H, Lipworth BJ.

Br J Clin Pharmacol. 2010 Jun;69(6):637-44. doi: 10.1111/j.1365-2125.2010.03655.x.

14.

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group.

N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.

15.

Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.

Richter DC, Joubert JR, Nell H, Schuurmans MM, Irusen EM.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):693-9.

16.

A randomized, double-blind, placebo-controlled trial of Lessertia frutescens in healthy adults.

Johnson Q, Syce J, Nell H, Rudeen K, Folk WR.

PLoS Clin Trials. 2007 Apr 27;2(4):e16.

17.

Heritable variation in seed sex ratio of the stinging nettle (Urtica dioica).

de Jong TJ, Nell HW, Glawe GA.

Plant Biol (Stuttg). 2005 Mar;7(2):190-4.

PMID:
15822015
18.

Therapeutic equivalence study of two formulations (innovator v. generic) of beclomethasone dipropionate in adult asthmatic patients.

Nell H, Louw CM, Cyster H, Williams Z, Bardin PG, Joubert JR.

S Afr Med J. 2001 Jan;91(1):51-6.

PMID:
11236299
19.

Fatal complication of paraffin plombage after half a century.

Nell H, Buxbaum A, Czedron A, Vetter N.

Wien Klin Wochenschr. 1998 Oct 30;110(20):729-31.

PMID:
9857432
20.

Positive and negative effects of herbivory on the population dynamics of Senecio jacobaea L. and Cynoglossum officinale L.

Prins AH, Nell HW.

Oecologia. 1990 Jun;83(3):325-332. doi: 10.1007/BF00317555.

PMID:
28313002

Supplemental Content

Loading ...
Support Center